[en] The interest in sexual dysfunction induced by psychotropic drugs has increased considerably in recent years because of the new-generation antidepressants (AD) and antipsychotics (AP) being put into medical practice. These drugs are widely used to treat not only depression and schizophrenia, but also anxiety and affective disorders. Other, additional indications for the use of antidepressants are appetite disorders, premenstrual syndrome, chronic pain, etc. Neuroleptics are administered to treat resistant depressions, aggressiveness, impulsivity, and alcoholism. Impaired sexual functioning due to AD and AP lowers quality of life in patients and increases the risk of their refusing treatment, the result of which is a phenomenon associated with the occurrence of recurrent mental illnesses. There are few scientific data on the nature and prevalence of sexual dysfunctions induced by these medications. This topic is universally underestimated as it is rarely touched upon by specialists during their consultations. The aim of the review is to show the side effects of AP and AD on the sexual sphere, to compare different classes of the drugs, and to propose possible management strategies to correct these undesirable effects.
Disciplines :
Psychiatry
Author, co-author :
LICITSYNA, Olga
Ansseau, Marc ; Université de Liège - ULiège > Département des sciences cliniques > Psychiatrie et psychologie médicale
GERNAY, Delphine ; Centre Hospitalier Universitaire de Liège - CHU > Psychiatrie et psychologie médicale
PITCHOT, William ; Centre Hospitalier Universitaire de Liège - CHU > Psychiatrie et psychologie médicale
Bertrand, Jean
Language :
Russian
Title :
Sexual dysfunction induced by antidepressants and antipsychotics
Baldwin, D.S., Depression and sexual dysfunction (2001) Br Med Bui, 57, pp. 81-99
Segraves, R.T., Dealing with sexual side effects (2008) Harv Ment Health Lett, 24 (11), pp. 6-14
Spector, L.P., Carey, M.P., Incidence and prevalence of the sexual dysfunction: A critical review of the empirical literature (1990) Arch Sex Behav, 19, pp. 389-408
Clayton, A.H., McGarvey, E.L., Clavet, G.J., The changes in sexual functioning questionnaire (CSFQ): Development, reliability, and validity (1997) Psychopharmacol Bui, 33 (4), pp. 731-745
McGahuey, C.A., Gelenberg, A.J., Laukes ÑË, The Arizona sexual experience scale (AS EX): Validity and reliability (2000) J Sex Marital Ther, 26, pp. 25-40
Serretti, A., Chiesa, A., Sexual side effects of pharmacological treatment of psychiatric diseases (2011) Clin Pharmacol Ther, (89), pp. 142-147
Casper, R.C., Redmond, E., Katz, M.M., Schaffer, C.B., Somatic symptoms in primary affective disorders: Presence and relationship to the classification of depression (1985) Arch Gen Psychiatry, 42, pp. 1098-1104
Baggaley, M., Sexual dysfunction in schizophrenia: Focus on recent evidence (2008) Hum Psychopharmacol Clin Exp, 23, pp. 201-209
Montejo-Gonzalez, A.L., Liorca, G., Isquierdo, J.A., SSRI-in-duced sexual-dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients (1997) J Sex Marital Ther, 23, pp. 176-194
Balon, R., Segraves, R.T., (2009) Clinical Manual of Sexual Disordres, pp. 95-115. , American Psychiatric Publishing, Inc. Washington, DC London, England
Manuel diag-nostique et statistique des troubles mentaux: Texte r6visi? (2003) [Bro-chd] Masson, pp. 617-675. , American Psychiatric Association. DSM-IV-TR
Montejo, A.L., Riesgo, Y., Luque, J., Observational, open-label, prospective multicenter study of sexual function in patients starting treatment with aripiprazole Actas Esp Psiquiat 2010, 38 (1), pp. 13-21
Segraves, R.T., Balon, R., Sexual pharmacology (2003) Fast Facts, pp. 29-72. , New York, London: W.W. Norton & Company
Bymaster, F.P., Dreshfield-Ahmad, L.J., Threlkeld, P.G., Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors (2001) Neuropsychopharmacology, 25, pp. 871-880
Licitsyna, O., Ansseau, M., Pitchot, W., Dysfonctions sexuelles et antid6presseurs (2011) Rev Med Lifege, 66 (2), pp. 69-74
Kennedy, S.H., Treating each and every depressed patient (2008) J Psychopharmacology, 22 (SUPPL. 7), pp. 19-23
Kennedy, S.H., Sexual dysfunction depression, and the impact of antidepressants (2009) J Clin Psychopharmacol, 29, pp. 157-164
Balon, R., SSRI-associated sexual dysfunction (2006) Am J Psychiatry, 163 (9), pp. 1504-1509
Zajecka, J.M., Augmentation strategies to increase antidepressant Tolerability (2007) J Clin Psychiatry, 68 (SUPPL. 10), pp. 23-27
Werneke, U., Northey, S., Bhugra, D., Antidepressants and sexual dysfunction (2006) Acta Psychiatr Scand, 114, pp. 384-397
Taylor, M.J., Rudkin, L., Hawton, Ê., Strategies for managing antidepressant-induced sexual dysfunction. Systematic review of randomized controlled trials (2005) J Affective Disorders, 88, pp. 241-254
Segraves, R.T., Sexual dysfunction associated with antidepressant (2007) Ther Urol Clin North Am, 34, pp. 575-579
Serretti, A., Chiesa, A., A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics (2011) Intem Clin Psychopharmacol, 26 (3), pp. 130-140
Martin-Du Pan, R., Baumann, P., Dysfunctions sexuelles induites par les àï̧eth
ã åâçåèãå et les antipsychotiques et leurs traitements (2008) Revue Mddicale Suisse, 4, pp. 758-762
Williams, V.S., Edin, H.M., Hogue, S.L., Prevalence and impact of antidepressant-associated sexual dysfunction in the three European countries: Replication in a cross-sectional patient survey (2010) J Psychopharmacol, 24 (4), pp. 489-496
